Skip to main content
TEM logo

TEM · Tempus AI, Inc.

Track TEM — free
$70.69 +2.21 (+3.23%) At close · Aug 27
Market Cap
$12.36B
Shares
180.43M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$70.69 Open$68.65 Day$67.80–71.89 52W close$41.55–103.25 Avg vol 30d6.8M Short int29.9M · 16.6% float · 7.3d Short vol50% Last earningsJul 30, 2026 DataJun 2024–Aug 2026 Filing10-Q · Jul 30

Up next

Next earnings call
Oct 25, 2026 Est · unconfirmed · in 8 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Jul 30, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 14.5 · calm Equity put/call 0.39
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +25%
      above
      Price vs 50-day avg +31%
      above
      RSI (14) 68
      neutral
      MACD trend Positive
      52-week position 47%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +60%
      trailing
      6-month return +35%
      trailing
      YTD return +20%
      this year
      Relative strength +21%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $54 › 200d $57 — 200d above 50d
      Institutional flow Accumulating
      +15% holders QoQ · +125 funds added
      Insider flow Distributing
      Net -$8.9M over 90 days · 100% sells
      Short interest Falling
      16.56% of float · ▼ -10.1% MoM · 7.3 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      497 holders — near 2-yr high, broad support
      Squeeze score 73
      high risk · 0–100
      Fundamentals
      Strong
      Revenue growth +83%
      Y/Y
      EPS growth +77%
      Y/Y
      Free cash flow $-239.1M
      Balance sheet $604.8M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 72%
      annualized · 1-yr
      Max drawdown −60%
      past year
      ATR 6.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Jul 30, 2026
      Adjusted EBITDA · full year 2026 Non-GAAP Maintained $65M
      May 5, 2026 $65M changed to Jul 30, 2026 $65M
      Prior guidance period ended · from the Earnings Call filed Jun 30, 2025
      Full year 2025 revenue · full year 2025 $1.26B
      Adjusted EBITDA · full year 2025 $5M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 4 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +25% Bullish
      Price vs 50-day avg
      +31% Bullish
      RSI (14)
      68 Neutral
      MACD trend
      Positive Bullish
      52-week position
      47% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $54 › 200d $57 — 200d above 50d
      Institutional flow Accumulating
      +15% holders QoQ · +125 funds added
      Insider flow Distributing
      Net -$8.9M over 90 days · 100% sells
      Short interest Falling
      16.56% of float · ▼ -10.1% MoM · 7.3 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      497 holders — near 2-yr high, broad support
      Price context
      position in its 52-week range
      Range low $42 Now $71 · 47% Range high $103
      vs 200-day avg +25% vs 50-day avg +31%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      GAAP → non-GAAP reconciliation
      GAAP Net income (loss) 5.64M
      -3.9M Interest income
      +10.28M Interest expense
      +7.13M Depreciation
      +18.86M Amortization
      +309K Provision for (benefit from) income taxes
      +2.86M Losses from equity method investments
      -97.4M Fair value changes
      +54.12M Stock-based compensation expense
      +1.49M Employer payroll tax related to stock-based compensation
      +990K Acquisition related expenses
      -3.99M Amortization of technology license
      +0K Franchise taxes related to IPO
      +11.64M Loss on debt extinguishment
      = Adjusted EBITDA 8.04M
      Hereditary revenue growth 5% Q2 2026
      Hereditary volume growth 54% Q1 2026
      Non-GAAP gross margin non-GAAP 65% Three Months Ended March 31, 2026
      Non-GAAP gross margin, data and applications non-GAAP 73.1% Three Months Ended March 31, 2026
      Non-GAAP gross margin, diagnostics non-GAAP 62.3% Three Months Ended March 31, 2026
      Non-GAAP gross profit non-GAAP $226.23M Three Months Ended March 31, 2026
      GAAP → non-GAAP reconciliation
      GAAP Gross profit 222.04M
      +3.68M Stock-based compensation expense
      +518K Employer payroll tax related to stock-based compensation
      = Non-GAAP gross profit 226.23M
      Non-GAAP gross profit, data and applications non-GAAP $63.64M Three Months Ended March 31, 2026
      GAAP → non-GAAP reconciliation
      GAAP Gross profit, data and applications 61.9M
      +1.55M Stock-based compensation expense
      +184K Employer payroll tax related to stock-based compensation
      = Non-GAAP gross profit, data and applications 63.64M
      Non-GAAP operating expenses non-GAAP $237.81M Three Months Ended March 31, 2026
      Non-GAAP research and development non-GAAP $43.19M Three Months Ended March 31, 2026
      Non-GAAP selling, general and administrative non-GAAP $159.02M Three Months Ended March 31, 2026
      Non-GAAP technology research and development non-GAAP $35.6M Three Months Ended March 31, 2026
      Net Revenue Retention 126% Full Year 2025
      Total Remaining Contract Value 1.1B Full Year 2025
      Total Contract Value (TCV) 1.1B full year 2025

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Health Information Services — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      TEM
      Tempus AI, Inc.
      this stock
      $12.36B +19.7% +83.4% 16.6%
      VEEV
      Veeva Systems Inc
      $39.78B +26.4% +28.1% 43.4 3.6%
      PMDIY
      Pro Medicus Ltd./ADR
      $13.02B -24.9% 0.0%
      BTSG
      BrightSpring Health Services, Inc.
      $12.25B +62.6% +28.2% 37.5 4.5%
      TXG
      10x Genomics, Inc.
      $8.37B +297.6% +68.1% 12.2%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      497
      % held
      75.7%
      Net QoQ
      +10.4M sh
      Top holder
      ARK Investment Management…
      Held Float
      View
      Held by Funds
      Fund positions
      242
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      29.9M
      Days to cover
      7.3d
      Change
      -3.4M sh
      View
      Short Volume
      Short vol %
      50%
      As of
      Aug 27, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      20.3K
      Value
      $1.1M
      As of
      Jul 20, 2026
      View
      Off-Exchange
      Off-exchange %
      48.8%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$8.9M
      Buyers / Sellers
      0 / 3
      Buyers Sellers
      View
      Congressional Trades Buy
      Member
      Nancy Pelosi
      Amount
      $50.0K–$100.0K
      Traded
      Jan 16, 2026
      View
      Financials
      Financials
      Revenue (FY)
      $1.3B
      Net income (FY)
      $-245.0M
      EPS diluted
      $-1.41
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jul 30, 2026
      This year
      15
      View
      Proposed Sales
      Value
      $952.2K
      Shares
      14.3K
      Filed
      Aug 21, 2026
      View
      Exempt Offerings
      Offering
      $10.0M
      Filed
      Oct 17, 2022
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 30, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      TEM +6.1% +59.6% +35.3% +61.1% +19.7%
      SPY +1.1% +4.0% +14.7% +3.2% +13.1%
      vs SPY +5.0% +55.6% +20.6% +57.9% +6.6%
      Key facts CIK 1717115 CUSIP 88023B103 13F (30d) 383 filings 381 filers Visit website Investor relations